State Enterprise Pharmaceutical Factory No.3

Always Innovation for Health

About PDC3

PDC3 is a state-owned pharmaceutical enterprise specializing in pharmaceutical research, development, and production. We focus on medicines for treating anemia, vitamins, antipyretics, analgesics, and cough medications.

Since our establishment in 1987, we have been committed to producing high-quality pharmaceutical products that meet international standards. Our dedication to research and development has positioned us as a leader in the pharmaceutical industry.

We continuously strive to improve our manufacturing processes and implement stringent quality control measures. Our facility operates in accordance with ISO standards and Good Manufacturing Practice (GMP) guidelines, ensuring the safety and efficacy of our products.

Our Journey

1987
PDC3 was established as a government pharmaceutical research and production facility.
1983
Partnership with Macao Iakala for technical cooperation and production expansion.
1987-1990
Installation and commissioning of modern pharmaceutical production equipment.
2000
Expanded production capacity with investment exceeding 100 million kip.
2006
Obtained ISO certification and implemented QA/QC systems.
2011-2015
Achieved GMP certification and expanded product portfolio. 2018
2018
Partnership with TSUJIKO Co Ltd for technology transfer and quality enhancement.

Company Statistics

Total Employees
0
Female Employees
0
Permanent Staff
0
Technical Personnel
0

Production Capacity

Injections per Day
0 K
Tablets per Day
0 K
Capsules per Day
0 M
Syrups per Day
0 M
Ointments per Day
0 K
Eye Drops per Day
0 K

Certifications & Quality Standards

1983

Technical cooperation agreement with JICA and Macao Iakala for pharmaceutical production

1987

Establishment of pharmaceutical research and production facility

1988

Installation of modern production equipment and quality control systems

2000

Major facility expansion with 100 million kip investment in modern equipment

2001

Implementation of advanced pharmaceutical production technologies

2006

Achieved ISO certification and QA/QC standards including Kaldect Tea, Dechlosal Tea, and Aromatic products

2011-2015

Obtained GMP certification for pharmaceutical production facilities

2018

Technology partnership with TSUJIKO Co Ltd for quality enhancement and product development

Strategic Partnerships

2018

Partnership agreement with Tsujiko Co., Ltd (Japan) and Consulus Pte Co. Ltd (Singapore) for technical cooperation and business development

2010-2015

Collaboration with KBN (Sino-American Kunming Baker Norton Pharmaceutical Co.) for production and distribution

1995-2004

Partnership with Labiofam SA for production of medicines, including pharmaceutical research and development of traditional and modern medicines

Research & Development

Our Research and Development department is dedicated to innovation in pharmaceutical sciences. We focus on both traditional medicine research and modern pharmaceutical development, ensuring our products meet the highest standards of efficacy and safety.

Our R&D team conducts extensive research on medicinal plants and herbs, analyzing their therapeutic properties and developing new formulations. We have successfully developed over 10 types of medicines derived from natural sources, combining traditional knowledge with modern scientific methods.

Medicinal Plant Research

Vision & Core Values

PDC3 is committed to producing high-quality medicines that meet the needs of the people and to becoming a modern, competitive enterprise in international markets.

01

Professionalism

We maintain professional standards with dedicated, skilled personnel who possess extensive knowledge in pharmaceutical production. Our 3 production lines are operated by highly qualified professionals who consistently deliver excellence, responding to market demands with precision and adhering to production schedules.

02

Total Quality

We are committed to comprehensive quality assurance across all processes. With 3 production lines dedicated to high-quality pharmaceutical manufacturing, we implement rigorous quality control measures throughout our operations, ensuring every product meets the highest standards of safety and efficacy.

03

Innovation

We embrace modern production technologies and continuously seek opportunities to develop innovative products that meet market needs. By leveraging ISO-certified quality systems and advanced research capabilities, we develop new medicines and improve existing formulations, ensuring our products remain at the forefront of pharmaceutical innovation while maintaining affordability and accessibility.

04

Unity

We foster a culture of teamwork and collaboration across all levels of our organization. Our 3 production lines operate in harmony, with skilled professionals working together toward common goals. We maintain strong relationships with partners and stakeholders, cultivate a supportive work environment, and empower our employees to contribute their expertise. Through unity, we achieve operational excellence, overcome challenges together, and strengthen our commitment to serving the community.